好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Mesenchymal Stem Cells from Patients with Secondary Progressive Multiple Sclerosis Show Deficient Immunomodulatory Activity towards Homologous Immune Cells
Multiple Sclerosis
P1 - (-)
388
Authors/Disclosures
Cris S. Constantinescu, MD, PhD (Cooper Neurological Institute)
PRESENTER
Dr. Constantinescu has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
Radu Tanasescu, MD, PhD, FAAN (Clinical Neurology) Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Bruno Gran, MD, PhD (Nottingham University Hospitals) Dr. Gran has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Gran has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche UK. Dr. Gran has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file